Malignant transformation of liver adenoma: An analysis of the literature

Digestive Surgery

Volumn 27, Issue 1, 2010, Pages 32-38

  Farges, Olivier ^a   Dokmak, Safi ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Androgens; Fanconi's anemia; Focal nodular hyperplasia; Glycogen storage disease; Hepatic adenoma; Hepatocellular carcinoma; Liver adenoma, malignant transformation; Oral contraception

Indexed keywords

ADENOMA; ARTICLE; CELL TRANSFORMATION; FEMALE; HUMAN; LIVER TUMOR; MALE; PATHOLOGY;

ADENOMA; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE;

EID: 77950543437     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000268405     Document Type: Article

References (42)

1. Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc JF, et al: Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005; 128: 1211-1218.
2. Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P: Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997; 26: 891-895.
3. Huurman VAL, Schaapherder AFM: Management of ruptured hepatocellular adenoma. Dig Surg 2010 (in press).
4. Davis M, Portmann B, Searle M, Wright R, Williams R: Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J 1975; 4: 496-498.
5. World Health Organization International - Agency for Research on Cancer (IARC): Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 91: Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy. Lyon, IARC, 2007, pp 95-103 [available at http://monographs.iarc.fr/ ENG/Monographs/vol91/mono91.pdf].
6. Larson KA, Weber SM, Fong Y, Blumgart LH: Malignant transformation of hepatic adenoma with recurrence after resection. HPB (Oxford) 2002; 4: 139-143.
7. Gordon SC, Reddy KR, Livingstone AS, Jeffers LJ, Schiff ER: Resolution of a contraceptive- steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med 1986; 105: 547-549.
8. Bioulac-Sage P, Balabaud C, Zucman-Rossi J: Subtype classification of hepatocellular adenoma. Dig Surg 2010;27:39-45.
9. Zucman-Rossi J, Jeannot E, Tran Van Nhieu J, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, et al: Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43: 515-524.
10. Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M: Malignant transformation of hepatic adenomas. Mod Pathol 2008; 21: 491-497.
11. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J: Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50: 481-489.
12. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J: A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137: 1698-1705.
13. Kogure T, Ueno Y, Sekiguchi S, Ishida K, Igarashi T, Wakui Y, Iwasaki T, Shimosegawa T: Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma. World J Gastroenterol 2009; 15: 1267-1272.
14. Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF 2nd: Hepatic adenoma and focal nodular hyperplasia: clinical, pathological and radiological features. Gastroenterology 1983; 84: 994-1002.
15. Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N: Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 1986; 160: 53-58.
16. Leese T, Farges O, Bismuth H: Liver cell adenomas. A 12-year surgical experience from a specialist hepatobiliary unit. Ann Surg 1988; 208: 558-564.
17. Arrive L, Flejou JF, Vilgrain V, Belghiti J, Najmark D, Zins M, Menu Y, Tubiana JM, et al: Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994; 193: 507-512.
18. Foster JH, Berman MM: The malignant transformation of liver cell adenomas. Arch Surg 1994; 129: 712-717
19. Nagorney DM: Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995; 19: 13-18.
20. Weimann A, Ringe B, Klempnauer J, Lamesch P, et al: Benign liver tumors: differential diagnosis and indicators for surgery. World J Surg 1997; 21: 983-990.
21. Ichikawa T, Federle MP, Grazioli L, Nalesnik M: Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000; 214: 861-868.
22. Reddy KR, Kligerman S, Levi J, Livingstone A, et al: Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001; 67: 173-178.
23. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJzermans JN: Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001; 136: 1033-1038.
24. Toso C, Majno P, Andres A, Rubbia-Brandt L, Berney T, Buhler L, Morel P, Mentha G: Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol 2005; 11: 5691-5695.
25. Van der Windt DJ, Kok NFM, Hussain SM, Zondervan PE, Alwayn IPJ, de Man RA, Ijzermans JNM: Case-oriented approach to the management of hepatocellular adenoma. Br J Surg 2006; 93: 1495-1502.
26. Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin TC: Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 2008; 15: 2795-2803.
27. Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, Martin RCG, d'Angelica M, et al: Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009; 16: 640-648.
28. Evert M, Dombrowski F: Hepatocellular carcinoma in the non-cirrhotic liver. Pathologe 2008; 29: 47-52.
29. Bralet MP, Regimbeau JM, Pineau P, Dubois S, Loas G, Degos F, Valla D, Belghiti J, et al: Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000; 32: 200-204.
30. Bege T, Le Treut YP, Hardwigsen J, Ananian P, Richa H, Campan P, Garcia S: Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series. J Gastrointest Surg 2007; 11: 619-625.
31. Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, et al: Treatment and prognosis of hepatocellular carcinoma: a population-based study in France. J Surg Oncol 2008; 98: 505-509.
32. Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, Bedossa P, Belghiti J: Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009; 49: 851-859.
33. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr: Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242: 644-648.
34. Tao LC: Are oral contraceptive-associated liver cell adenomas premalignant? Acta Cytol 1992; 36: 338-344.
35. Alter BP: Cancer in Fanconi anemia, 1927- 2001. Cancer 2003; 97: 425-440.
36. Velasquez I, Alter BP: Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004; 77: 257-267.
37. Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, et al: Glycogen storage disease in adults. Ann Intern Med 1994; 120: 218-226.
38. Franco LM, Krishnamurthy V, Bali D, Weinstein DA, Arn P, Clary B, et al: Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 2005; 288: 153-162.
39. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M: Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24: 276-279.
40. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit PA: Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Result of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002; 161:S20-S34.
41. Reddy SK, Kishnani PS, Sullivan JA, Koeberl DD, Desai DM, Skinner MA, Rice HE, Clary BM: Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 2007; 47: 658-663.
42. Veteläinen R, Erdogan D, de Graaf W, ten Kate F, Jansen PLM, Gouma DJ, van Gulik TM: Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008; 28: 499-508.